Testing a mobile app to help prevent suicide

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to pilot test a personalized mobile application designed to prevent suicide, known as MAPS. It will assess the feasibility, acceptability, and preliminary efficacy of the app in reducing suicidal ideation and behavior among young adults. Participants will be individuals aged 18 to 26 who have experienced suicidal thoughts or behaviors in the past month. The study will also evaluate safety and the potential need for re-hospitalization.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Suicidal ideation and/or suicidal behavior in the past month verified by the C-SSRS
* Between the ages of 18 and 26
* English proficiency
* Comfortable with smartphone technology
* Deemed by the treatment team to be stable enough to complete study procedures

Exclusion Criteria:

* Current psychotic or manic symptoms severe enough to interfere with study procedures

Where it's running

• Butler Hospital
  Providence, Rhode Island, United States Recruiting

Study contacts

• Study coordinator: Cheryl Cordeiro
• Email: ccordeiro@butler.org
• Phone: 401-455-6654

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Intensive Crisis Intervention for teens with suicidal thoughts or behaviors

  This project will try a brief, family-focused Intensive Crisis Intervention to see if it helps 12–17-year-olds with suicidal thoughts or recent attempts reduce suicidal behavior and avoid inpatient psychiatric care.

  Recruiting Nationwide Children's Hospital · Columbus, Ohio · NCT06476886

• Enhanced Outreach After ED Visit to Prevent Suicide Attempts

  This study tests a weekly outreach program by a crisis organization after an ED visit for suicidal thoughts to see if it’s doable and helpful for participants.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT05825820

• New treatment method for reducing suicidality after a crisis

  This study is testing a new short-term treatment for people who have recently tried to harm themselves to see if it can help reduce feelings of hopelessness and improve support from family and friends.

  Recruiting at 12 sites University Hospital, Ghent · Beernem and 11 other locations · NCT05638204

• Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression

  This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.

  Recruiting Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Madrid, Madrid · NCT07885722

• Inhaled DMT for major depressive disorder

  This trial tests whether inhaled DMT can quickly ease depressive symptoms and reduce suicide risk in adults with major depressive disorder.

  Recruiting Phase 2 Universidade Federal do Rio Grande do Norte · Fortaleza, Ceará and 4 other locations · NCT07562191

• Mindfulness-based programs for suicidal thoughts and self-harm in Korean youth

  We will test whether two mindfulness-based programs for Korean adolescents and young adults reduce suicidal thoughts, self-harm, depression, and problems with sleep and emotion regulation.

  Recruiting Ajou University School of Medicine · Suwon, Gyeonggi-do · NCT07395752

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.